HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Barin, J. G. Articles by Caturegli, P. Search for Related Content PubMed PubMed Citation Articles by Barin, J. G. Articles by Caturegli, P.

Thyroid-Specific Expression of IFN- Limits Experimental Autoimmune Thyroiditis by Suppressing Lymphocyte Activation in Cervical Lymph Nodes¹

Jobert G. Barin^*, Marina Afanasyeva^*,, Monica V. Talor^*, Noel R. Rose^*,, C. Lynne Burek^*, and Patrizio Caturegli^2,*

^* Department of Pathology, School of Medicine, and W. Harry Feinstone Department of Molecular Microbiology and Immunology, Bloomberg School of Public Health, Johns Hopkins University, Baltimore, MD 21205

The role of IFN- in the pathogenesis of autoimmune disease is controversial, being described as immunostimulatory in some studies and immunosuppressive in others. To determine the contribution of local expression of IFN-, we derived NOD.H-2^h4 transgenic mice overexpressing IFN- in a thyroid-restricted manner. Transgenic mice, which had serum IFN- levels similar to wild-type littermates, showed up-regulation of MHC class II on thyrocytes, but did not develop spontaneous thyroiditis. Upon immunization with murine thyroglobulin, transgenic mice developed milder disease and reduced IgG1 responses compared with wild type. The milder disease was associated with decreased frequency of activated CD44⁺ lymphocytes in the cervical lymph nodes. This suppressive effect was confirmed by showing that blockade of systemic IFN- with mAb enhanced disease and increased IgG1 responses. The study supports a disease-limiting role of IFN- in autoimmune thyroiditis. Furthermore, it provides the first evidence that local IFN- activity in the thyroid is sufficient for disease suppression.

This article has been cited by other articles:

				X. Wu, W. Hou, S. Sun, E. Bi, Y. Wang, M. Shi, J. Zang, C. Dong, and B. Sun Novel Function of IFN-{gamma}: Negative Regulation of Dendritic Cell Migration and T Cell Priming J. Immunol., July 15, 2006; 177(2): 934 - 943. [Abstract] [Full Text] [PDF]

				S. Yu, G. C. Sharp, and H. Braley-Mullen Thyrocytes Responding to IFN-{gamma} Are Essential for Development of Lymphocytic Spontaneous Autoimmune Thyroiditis and Inhibition of Thyrocyte Hyperplasia J. Immunol., January 15, 2006; 176(2): 1259 - 1265. [Abstract] [Full Text] [PDF]

				S. H. Wang, Z. Cao, J. M. Wolf, M. Van Antwerp, and J. R. Baker Jr. Death Ligand Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand Inhibits Experimental Autoimmune Thyroiditis Endocrinology, November 1, 2005; 146(11): 4721 - 4726. [Abstract] [Full Text] [PDF]

				H. Kimura, S.-C. Tzou, R. Rocchi, M. Kimura, K. Suzuki, A. F. Parlow, N. R. Rose, and P. Caturegli Interleukin (IL)-12-Driven Primary Hypothyroidism: the Contrasting Roles of Two Th1 Cytokines (IL-12 and Interferon-{gamma}) Endocrinology, August 1, 2005; 146(8): 3642 - 3651. [Abstract] [Full Text] [PDF]

				R. B. Sharma, J. D. Alegria, M. V. Talor, N. R. Rose, P. Caturegli, and C. L. Burek Iodine and IFN-{gamma} Synergistically Enhance Intercellular Adhesion Molecule 1 Expression on NOD.H2h4 Mouse Thyrocytes J. Immunol., June 15, 2005; 174(12): 7740 - 7745. [Abstract] [Full Text] [PDF]

				M. Afanasyeva, D. Georgakopoulos, D. F. Belardi, D. Bedja, D. Fairweather, Y. Wang, Z. Kaya, K. L. Gabrielson, E. R. Rodriguez, P. Caturegli, et al. Impaired up-regulation of CD25 on CD4+ T cells in IFN-{gamma} knockout mice is associated with progression of myocarditis to heart failure PNAS, January 4, 2005; 102(1): 180 - 185. [Abstract] [Full Text] [PDF]